Investor Contacts

Investor Contacts

For questions about Investor Relations or the Share Registry, please contact our team.

For all other queries:

Main Switchboard

Switzerland
Phone: +41 61 324 11 11

US Switchboard

Phone: +1 862 778 21 00

 

For information regarding the share register (entries, transfers, dividends, etc.) please contact:

E-mail addressshare.registry@novartis.com
Postal addressNovartis International AG
Share Registry
Forum 1-2.77
P.O. Box
4002 Basel
Switzerland
Phone number+41 61 324 72 04


You can notify the Share Registry of a change of address using the following form:
 
Change of address: Online form

Note: Most Swiss custodian banks automatically notify the stock corporations of their customers’ address changes to be applied in the share register.

Email address:

investor.relations@novartis.com


Imke Kappes

Phone: +41 61 324 82 69


Isabella Zinck

Phone: +41 61 324 71 88


Nicole Zinsli-Somm

Phone: +41 61 324 38 09


Mailing address:

Novartis International AG
Investor Relations
P.O. Box
CH - 4002 Basel / Switzerland
Phone: +41 61 324 79 44
Fax: +41 61 324 84 44

Email address:

investor.relations@novartis.com


Sloan Simpson

Head of Investor Relations

Phone: +1 862 345 44 40


Jonathan Graham

Phone: +1 201 602 99 21


Parag Mahanti

Phone: +1 973 876 49 12


Mailing address:

Novartis Pharmaceuticals
One Health Plaza
East Hanover, NJ 07936


Source URL: https://prod1.novartis.com/contacts/investor-contacts

List of links present in page
  1. https://prod1.novartis.com/contacts/investor-contacts
  2. #tabshare-registry-30686
  3. #tabir-europe-30691
  4. #tabir-north-america-30696
  5. mailto:share.registry@novartis.com
  6. https://prod1.novartis.com/investors/shareholder-address-change
  7. mailto:investor.relations@novartis.com
  8. tel:0041613248269
  9. tel:0041613247188
  10. tel:0041613243809
  11. mailto:investor.relations@novartis.com
  12. tel:0018623454440
  13. tel:0012016029921
  14. tel:0019738764912